LEVEMIR Side Effects

7022080-X | Hypoglycaemic Unconsciousness, Pelvic Fracture
on Sep 20, 2010 Female patient from ITALY , weighting 222.7 lb, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic unconsciousness, pelvic fracture. Levemir dosage: 14 U, Qd. During the same period patient was treated with APIDRA (38 Iu, Qd) (View Apidra Review and Apidra Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NITRO DUR (View Nitro-dur Review and Nitro-dur Label ), LOBIVON (View Lobivon Review and Lobivon Label ), VALPRESSION (View Valpression Review and Valpression Label ). Patient was hospitalized.

7020480-5 | Cardiac Failure Congestive, Fluid Overload, Oedema Peripheral, Pulmonary Oedema
Patient was taking Levemir (View Usage). Patient had the following side effects: cardiac failure congestive, fluid overload, oedema peripheral, pulmonary oedema on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 294.8 lb, was diagnosed with type 2 diabetes mellitus, multiple myeloma (What is multiple myeloma?) and. Levemir dosage: Unk. During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), DEXAMETHASONE (10 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), VELCADE (3.2 Mg, Cyclic) (View Velcade Review and Velcade Label ), THALIDOMIDE (100 Mg, Cyclic) (View Thalidomide Review and Thalidomide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

7017821-1 | Malignant Neoplasm Of Ampulla Of Vater, Metastases To Pancreas
Adverse event was reported on Sep 23, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 18 Ul, Qd) . Location: MEXICO , 60 years of age, After Levemir was administered, patient had the following side effects: malignant neoplasm of ampulla of vater, metastases to pancreas. During the same period patient was treated with NOVORAPID FLEXPEN (12 Ul, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ).

7015047-9 | Accidental Overdose, Dehydration, Diarrhoea, Erysipelas, Hyperkalaemia, Hypoglycaemia, Hyponatraemia, Lactic Acidosis, Renal Failure Acute
on Sep 17, 2010 Female patient from FRANCE , 67 years of age, was diagnosed with type 2 diabetes mellitus, erysipelas, hypertension and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, dehydration, diarrhoea, erysipelas, hyperkalaemia, hypoglycaemia, hyponatraemia, lactic acidosis, renal failure acute. Levemir dosage: . During the same period patient was treated with METFORMIN (1000 Mg, Tid) (View Metformin Review and Metformin Label ), AMAREL (1 Df, Qd) (View Amarel Review and Amarel Label ), AUGMENTIN '125' (1 G, Tid) (View Augmentin '125' Review and Augmentin '125' Label ), BRISTOPEN /00040801/ (1 G, Bid) (View Bristopen /00040801/ Review and Bristopen /00040801/ Label ), ALTEIS (3 Df, Qd) (View Alteis Review and Alteis Label ), VASTEN /00880402/ (Tablet) (View Vasten /00880402/ Review and Vasten /00880402/ Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), HYDROCORTISONE (30 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.


7014561-X | Anti-insulin Antibody, Hyperglycaemia, Hypoglycaemia
on Sep 14, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: anti-insulin antibody, hyperglycaemia, hypoglycaemia. Levemir dosage: 6 U, Qd. During the same period patient was treated with NOVOLIN R (View Novolin R Review and Novolin R Label ), HUMALOG MIX 50 (24u/sc) (View Humalog Mix 50 Review and Humalog Mix 50 Label ), HUMACART N (View Humacart N Review and Humacart N Label ). Patient was hospitalized.

7009317-8 | Decreased Appetite, Hypoglycaemia, Vertigo, Weight Decreased
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: decreased appetite, hypoglycaemia, vertigo, weight decreased on Sep 15, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, weighting 187.4 lb, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 14 U, Qd. During the same period patient was treated with NOVORAPID (42 Iu, Qd) (View Novorapid Review and Novorapid Label ), ENALAPRIL (20 Mg, Qd) (View Enalapril Review and Enalapril Label ), LERCANIDIPINE (10 Mg, Qd) (View Lercanidipine Review and Lercanidipine Label ), OPIPRAMOL (50 Mg, Bid) (View Opipramol Review and Opipramol Label ). Patient was hospitalized.

7004844-1 | Depressed Level Of Consciousness, Hyperglycaemia, Hypoglycaemia, Hypokalaemia
Adverse event was reported on Sep 10, 2010 by a Female patient taking Levemir (View Usage) (Dosage: /sc) was diagnosed with type 1 diabetes mellitus and. Location: JAPAN , 26 years of age, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, hyperglycaemia, hypoglycaemia, hypokalaemia. Patient was hospitalized.

6987634-5 | Hypoglycaemic Unconsciousness, Pelvic Fracture
on Sep 06, 2010 Female patient from ITALY , weighting 222.7 lb, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness, pelvic fracture. Levemir dosage: 14 U, Qd. During the same period patient was treated with APIDRA (38 Iu, Qd) (View Apidra Review and Apidra Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NITRO DUR (View Nitro-dur Review and Nitro-dur Label ), LOBIVON (View Lobivon Review and Lobivon Label ), VALPRESSION (View Valpression Review and Valpression Label ). Patient was hospitalized.

6980808-9 | Blood Glucose Increased, Cerebrovascular Accident
on Sep 08, 2010 Female patient from UNITED STATES , 52 years of age, weighting 125.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: blood glucose increased, cerebrovascular accident. Levemir dosage: Unk. During the same period patient was treated with NOVOLOG (Sliding Scale, Prn) (View Novolog Review and Novolog Label ), ASPIRIN (325 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6980399-2 | Blood Glucose Increased, Decreased Appetite, Nausea
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, decreased appetite, nausea (What is nausea?) on Jun 30, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 40 U, Qd. During the same period patient was treated with VICTOZA (0.6 Mg, Qd, Subcutaneous) (View Victoza Review and Victoza Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6978251-1 | Atrial Fibrillation, Stress
Adverse event was reported on Sep 03, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 30 Iu, Bid) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 290.3 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), stress (What is stress?). During the same period patient was treated with NOVOLOG (10 Iu, Tid) (View Novolog Review and Novolog Label ). Patient was hospitalized.

6976138-1 | Blood Glucose Increased, Dermatitis Infected
on Sep 03, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with type 2 diabetes mellitus, thyroid disorder and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: blood glucose increased, dermatitis infected. Levemir dosage: Unk. During the same period patient was treated with VAGIFEM (25 Ug, Biw) (View Vagifem Review and Vagifem Label ), METFORMIN (1000 Mg, Bid) (View Metformin Review and Metformin Label ), GLIMEPIRIDE (8 Mg, Qd) (View Glimepiride Review and Glimepiride Label ), JANUVIA (100 Mg, Qd) (View Januvia Review and Januvia Label ), SYNTHROID (.075 Mg, Qd) (View Synthroid Review and Synthroid Label ), SIMVASTATIN (20 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), VITAMIN A (100000 Iu, Weekly) (View Vitamin A Review and Vitamin A Label ), ASPIRIN (81 Mg, Qd) (View Aspirin Review and Aspirin Label ).

6971862-9 | Hypoglycaemia
on Sep 08, 2010 Female patient from UNITED STATES , weighting 167.6 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Levemir dosage: 15 Units Twice Daily Subcutaneously. Patient was hospitalized.

6969228-0 | Application Site Erythema, Injection Site Pain
Patient was taking Levemir (View Usage). Patient had the following side effects: application site erythema, injection site pain on Aug 30, 2010 from PAKISTAN Additional patient health information: Male patient , 68 years of age, weighting 203.9 lb, was diagnosed with blood glucose abnormal and. Levemir dosage: 14 U, Qd. During the same period patient was treated with GLIMEPIRID (6 Mg, Qd) (View Glimepirid Review and Glimepirid Label ), METFORMIN (3 G, Qd) (View Metformin Review and Metformin Label ), ATENOLOL (100 Mg, Qd) (View Atenolol Review and Atenolol Label ), GEMFIBROZIL (600 Mg, Qd) (View Gemfibrozil Review and Gemfibrozil Label ), ATORVASTATIN (10 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ).

6966927-1 | Depressed Level Of Consciousness, Hyperglycaemia, Hypoglycaemia, Hypokalaemia
Adverse event was reported on Aug 25, 2010 by a Female patient taking Levemir (View Usage) (Dosage: /sc) was diagnosed with type 1 diabetes mellitus and. Location: JAPAN , 26 years of age, After Levemir was administered, patient had the following side effects: depressed level of consciousness, hyperglycaemia, hypoglycaemia, hypokalaemia. Patient was hospitalized.

6965837-3 | Convulsion, Fibromyalgia
on Aug 24, 2010 Female patient from UNITED STATES , 43 years of age, weighting 273.9 lb, was diagnosed with diabetes mellitus, fibromyalgia, mood swings, personality disorder (What is personality disorder?), sleep apnoea syndrome, blood pressure increased, blood cholesterol increased, pain (What is pain?), hypersensitivity and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, fibromyalgia. Levemir dosage: 47 U, Bid. During the same period patient was treated with LYRICA (150 Mg, Tid) (View Lyrica Review and Lyrica Label ), TEGRETOL (1200 Mg, Qd (400 Mg Am 800 Mg Pm)) (View Tegretol Review and Tegretol Label ), PROVIGIL (200 Mg, 1.5 Tabs Qd) (View Provigil Review and Provigil Label ), PROPRANOLOL (20 Mg, Bid) (View Propranolol Review and Propranolol Label ), SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), MELOXICAM (15 Mg, Bid) (View Meloxicam Review and Meloxicam Label ), CETIRIZINE HCL (10 Mg, Qd) (View Cetirizine Hcl Review and Cetirizine Hcl Label ).

6958579-1 | Blood Glucose Decreased
on Aug 30, 2010 Female patient from UNITED STATES , 44 years of age, weighting 329.0 lb, was diagnosed with diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: blood glucose decreased. Levemir dosage: 95 Units Qhs Sq.

6955736-5 | Injection Site Erythema, Product Contamination
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: injection site erythema, product contamination on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with diabetes mellitus and. Levemir dosage: 100 Units Daily Sq. During the same period patient was treated with CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), SINGULAIR (View Singulair Review and Singulair Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6955087-9 | Foetal Growth Restriction
Adverse event was reported on Aug 19, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 12 U, Qd) . Location: JAPAN , weighting 2.59 lb, Patient experienced the following unwanted or unexpected effects: foetal growth restriction. Patient was hospitalized.

6955033-8 | Hypertension, Oedema
on Aug 19, 2010 Female patient from JAPAN , weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: hypertension, oedema. Levemir dosage: 12 U, Qd. Patient was hospitalized.

6944823-3 | Cardiac Failure Congestive, Fluid Overload, Oedema Peripheral, Pulmonary Oedema
on Aug 17, 2010 Male patient from UNITED STATES , weighting 294.8 lb, was diagnosed with type 2 diabetes mellitus, multiple myeloma (What is multiple myeloma?) and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: cardiac failure congestive, fluid overload, oedema peripheral, pulmonary oedema. Levemir dosage: Unk. During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), DEXAMETHASONE (10 Mg, Cyclic) (View Dexamethasone Review and Dexamethasone Label ), VELCADE (3.2 Mg, Cyclic) (View Velcade Review and Velcade Label ), THALIDOMIDE (100 Mg, Cyclic) (View Thalidomide Review and Thalidomide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GUAIFENESIN (View Guaifenesin Review and Guaifenesin Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6944818-X | Anti-insulin Antibody, Anti-insulin Antibody Positive, Hyperglycaemia, Hypoglycaemia
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody, anti-insulin antibody positive, hyperglycaemia, hypoglycaemia on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 6 U, Unk. During the same period patient was treated with NOVOLIN N (5 U, Unk) (View Novolin N Review and Novolin N Label ), NOVOLIN R (View Novolin R Review and Novolin R Label ), HUMALOG MIX 50 (24u/sc) (View Humalog Mix 50 Review and Humalog Mix 50 Label ). Patient was hospitalized.

6942307-X | Blister, Pain, Pruritus, Urinary Tract Infection
Adverse event was reported on Aug 18, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 24 Iu, Qd) was diagnosed with type 2 diabetes mellitus and. Location: UNITED KINGDOM , 89 years of age, weighting 158.7 lb, Patient had the following side effects: blister, pain (What is pain?), pruritus, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6941047-0 | Device Failure, Fall
on Aug 18, 2010 Male patient from BRAZIL , 51 years of age, weighting 207.2 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: device failure, fall (What is fall?). Levemir dosage: 40 U, Qd. During the same period patient was treated with METFORMIN HCL (2 Tab, Qd) (View Metformin Hcl Review and Metformin Hcl Label ), VALSARTAN (320 Mg, Qd) (View Valsartan Review and Valsartan Label ), ANTI INFLAMMATORY (2 Tab, Qd) (View Anti Inflammatory Review and Anti Inflammatory Label ).

6936120-7 | Device Malfunction
on Aug 19, 2010 Male patient from UNITED STATES , 78 years of age, was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: device malfunction. Levemir dosage: .

6929966-2 | Injection Site Erythema, Injection Site Pruritus
Patient was taking Levemir (View Usage). Patient had the following side effects: injection site erythema, injection site pruritus on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 240.0 lb, was diagnosed with diabetes mellitus and. Levemir dosage: 50 Units Once Sq.

6927652-6 | Application Site Erythema, Injection Site Pain
Adverse event was reported on Aug 06, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 14 U, Qd) was diagnosed with blood glucose abnormal and. Location: PAKISTAN , 68 years of age, weighting 203.9 lb, After Levemir was administered, patient had the following side effects: application site erythema, injection site pain. During the same period patient was treated with GLIMEPIRID (6 Mg, Qd) (View Glimepirid Review and Glimepirid Label ), METFORMIN (3 G, Qd) (View Metformin Review and Metformin Label ), ATENOLOL (100 Mg, Qd) (View Atenolol Review and Atenolol Label ), GEMFIBROZIL (600 Mg, Qd) (View Gemfibrozil Review and Gemfibrozil Label ), ATORVASTATIN (10 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ).

6925521-9 | Device Failure, Fall, Tibia Fracture
on Aug 06, 2010 Male patient from BRAZIL , 51 years of age, weighting 207.2 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: device failure, fall (What is fall?), tibia fracture. Levemir dosage: 40 U, Qd. During the same period patient was treated with METFORMIN (2 Tab, Qd) (View Metformin Review and Metformin Label ), VALSARTAN (320 Mg, Qd) (View Valsartan Review and Valsartan Label ), ANTI INFLAMMATORY (2 Tab, Qd) (View Anti Inflammatory Review and Anti Inflammatory Label ).

6923185-1 | Diabetes Mellitus Inadequate Control, Diabetic Foot, Pulmonary Oedema
on Aug 05, 2010 Male patient from ISRAEL , 60 years of age, weighting 156.5 lb, was diagnosed with type 2 diabetes mellitus, diabetic foot and was treated with Levemir (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, diabetic foot, pulmonary oedema. Levemir dosage: 35 U, Qd. During the same period patient was treated with NOVORAPID FLEXPEN (10 U, Qd) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), MIXTARD HUMAN 70/30 (50 U, Qd) (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), ROCEPHIN (Unk) (View Rocephin Review and Rocephin Label ), CIPROXIN /00697201/ (View Ciproxin /00697201/ Review and Ciproxin /00697201/ Label ). Patient was hospitalized.

6913589-5 | Caesarean Section, Fallot's Tetralogy
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: caesarean section, fallot's tetralogy on Jul 29, 2010 from TUNISIA Additional patient health information: Female patient , weighting 8.38 lb, was diagnosed with type 1 diabetes mellitus and. Levemir dosage: 25 Iu, Qd. During the same period patient was treated with NOVORAPID (16 Iu, Qd) (View Novorapid Review and Novorapid Label ).

6907678-9 | Anti-insulin Antibody, Diabetes Mellitus Inadequate Control, Hypoglycaemia
Adverse event was reported on Jul 27, 2010 by a Female patient taking Levemir (View Usage) (Dosage: /sc) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 48 years of age, weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: anti-insulin antibody, diabetes mellitus inadequate control, hypoglycaemia. During the same period patient was treated with NOVORAPID CHU FLEXPEN (/sc) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN R (/sc) (View Novolin R Review and Novolin R Label ), NOVOLIN N (Unk) (View Novolin N Review and Novolin N Label ). Patient was hospitalized.

6907666-2 | Injection Site Haematoma, Injection Site Hypertrophy, Injection Site Necrosis
on Jul 28, 2010 Male patient from UNITED STATES , weighting 276.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: injection site haematoma, injection site hypertrophy, injection site necrosis. Levemir dosage: Unk. During the same period patient was treated with HUMALOG (Unk) (View Humalog Review and Humalog Label ), GLUCOPHAGE (Unk) (View Glucophage Review and Glucophage Label ).

6899959-2 | Nephropathy
on Jul 29, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: nephropathy. Levemir dosage: Unk. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6886763-4 | Anti-insulin Antibody Positive, Diabetes Mellitus Inadequate Control
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody positive, diabetes mellitus inadequate control on Apr 19, 2010 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with type 1 diabetes mellitus and. Levemir dosage: 8 Iu, Qd. During the same period patient was treated with HUMALOG (13 Iu, Qd) (View Humalog Review and Humalog Label ).

6882014-5 | Diabetes Mellitus Inadequate Control, Foetal Heart Rate Abnormal
Adverse event was reported on Jul 19, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 20 U, Qd) was diagnosed with type 1 diabetes mellitus, hypothyroidism and. Location: SOUTH AFRICA , 28 years of age, weighting 143.3 lb, Patient had the following side effects: diabetes mellitus inadequate control, foetal heart rate abnormal. During the same period patient was treated with NOVORAPID FLEXPEN (6-8 Units Thrice Daily) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), ELTROXIN (125 Ug, Qd) (View Eltroxin Review and Eltroxin Label ).

6880817-4 | Blister, Dyspepsia, Hypersensitivity, Malaise, Oedema
on Jul 20, 2010 Male patient from SWITZERLAND , 83 years of age, weighting 132.3 lb, was diagnosed with increased insulin requirement and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: blister, dyspepsia, hypersensitivity, malaise, oedema. Levemir dosage: 10 Iu / S.c..

6879756-4 | Diarrhoea, Hypocalcaemia, Hypokalaemia, Lipase Increased
on Jul 19, 2010 Female patient from GERMANY , weighting 165.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hypocalcaemia, hypokalaemia, lipase increased. Levemir dosage: 24 U, Qd. During the same period patient was treated with ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), AMLODIPIN /00972401/ (Unk) (View Amlodipin /00972401/ Review and Amlodipin /00972401/ Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6870846-9 | Asthenia, Tremor
Patient was taking Levemir (View Usage). Patient had the following side effects: asthenia, tremor on Jul 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 134.0 lb, was diagnosed with type 2 diabetes mellitus, angina unstable, hypertension and. Levemir dosage: 4 U, Qd In A.m.. During the same period patient was treated with RANEXA (500 Mg, Qd) (View Ranexa Review and Ranexa Label ), IMDUR (View Imdur Review and Imdur Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

6860378-6 | Blood Glucose Increased, Product Substitution Issue
Adverse event was reported on Jul 19, 2010 by a Female patient taking Levemir (View Usage) (Dosage: Daily Im) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 76 years of age, weighting 170.0 lb, After Levemir was administered, patient had the following side effects: blood glucose increased, product substitution issue.

6859987-X | Diabetes Mellitus Inadequate Control, Foetal Heart Rate Abnormal
on Jun 25, 2010 Female patient from SOUTH AFRICA , 28 years of age, weighting 143.3 lb, was diagnosed with type 1 diabetes mellitus, hypothyroidism and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, foetal heart rate abnormal. Levemir dosage: 20 U, Qd. During the same period patient was treated with NOVORAPID FLEXPEN (6-8 Units Thrice Daily) (View Novorapid Flexpen Review and Novorapid Flexpen Label ), ELTROXIN (125 Ug, Qd) (View Eltroxin Review and Eltroxin Label ).

6839755-5 | Pre-eclampsia
on Jul 06, 2010 Female patient from AUSTRALIA , weighting 134.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). Patient had the following side effects: pre-eclampsia. Levemir dosage: 36 U, Qd. During the same period patient was treated with NOVORAPID (40 U, Qd) (View Novorapid Review and Novorapid Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ).

6832206-6 | Anti-insulin Antibody Positive, Blood Glucose Increased, Diabetes Mellitus Inadequate Control, Iiird Nerve Paralysis, Lipohypertrophy
Patient was taking Levemir (View Usage). After Levemir was administered, patient had the following side effects: anti-insulin antibody positive, blood glucose increased, diabetes mellitus inadequate control, iiird nerve paralysis, lipohypertrophy on Jun 29, 2010 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with type 1 diabetes mellitus and. Levemir dosage: 6 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (18 U, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ). Patient was hospitalized.

6823257-6 | Abdominal Pain, Blood Glucose Increased, Diarrhoea
Adverse event was reported on Jun 28, 2010 by a Male patient taking Levemir (View Usage) (Dosage: 30 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: AUSTRALIA , 20 years of age, weighting 209.4 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood glucose increased, diarrhoea. During the same period patient was treated with NOVORAPID (12 Iu, Tid) (View Novorapid Review and Novorapid Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ).

6819331-0 | Blood Glucose Fluctuation, Cerebrovascular Accident, Decreased Appetite, Hypertension, Weight Decreased
on Jun 28, 2010 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Levemir (View Usage). Patient had the following side effects: blood glucose fluctuation, cerebrovascular accident, decreased appetite, hypertension, weight decreased. Levemir dosage: 100 Iu, Qd. During the same period patient was treated with LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6819330-9 | Anti-insulin Antibody, Diabetes Mellitus Inadequate Control, Hypoglycaemia
on Jul 02, 2010 Female patient from JAPAN , 48 years of age, weighting 112.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: anti-insulin antibody, diabetes mellitus inadequate control, hypoglycaemia. Levemir dosage: /sc. During the same period patient was treated with NOVORAPID CHU FLEXPEN (/sc) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN R (/sc) (View Novolin R Review and Novolin R Label ), NOVOLIN N (Unk) (View Novolin N Review and Novolin N Label ). Patient was hospitalized.

6815057-8 | Diabetic Ketoacidosis, Hypoglycaemia, Hypoglycaemic Encephalopathy, Liver Disorder
Patient was taking Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic ketoacidosis, hypoglycaemia, hypoglycaemic encephalopathy, liver disorder on Jun 25, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, type 1 diabetes mellitus, diabetic ketoacidosis and. Levemir dosage: 6 U, Qd. During the same period patient was treated with NOVORAPID CHU FLEXPEN (20 U, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN N (View Novolin N Review and Novolin N Label ), VEEN F (2500 Ml, Qd) (View Veen-f Review and Veen-f Label ), SOLITA T3 (Unk) (View Solita-t3 Review and Solita-t3 Label ). Patient was hospitalized.

6812178-0 |
Adverse event was reported on Jun 24, 2010 by a Female patient taking Levemir (View Usage) (Dosage: 32 Iu, Qd) was diagnosed with type 1 diabetes mellitus and. Location: JAPAN , 32 years of age, weighting 152.1 lb, . During the same period patient was treated with NOVOLIN N (Unk Iu, Qd) (View Novolin N Review and Novolin N Label ).

6812177-9 | Gestational Hypertension
on Jun 22, 2010 Female patient from AUSTRALIA , weighting 134.5 lb, was diagnosed with type 1 diabetes mellitus and was treated with Levemir (View Usage). After Levemir was administered, patient had the following side effects: gestational hypertension. Levemir dosage: 36 U, Qd. During the same period patient was treated with NOVORAPID (40 U, Qd) (View Novorapid Review and Novorapid Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ).

6800697-2 | Myocardial Infarction
on Jun 23, 2010 Female patient from GREECE , weighting 244.7 lb, was diagnosed with diabetes mellitus, dyslipidaemia, hypertension and was treated with Levemir (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Levemir dosage: 8 Unk, Bid. During the same period patient was treated with NOVORAPID (16 Unk, Qid) (View Novorapid Review and Novorapid Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ).

6790124-6 | Hypoglycaemic Unconsciousness, Hypotension
Patient was taking Levemir (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness, hypotension on Jun 15, 2010 from IRELAND Additional patient health information: Female patient , 79 years of age, was diagnosed with type 2 diabetes mellitus and. Levemir dosage: 20 U, Qd. During the same period patient was treated with NOVORAPID (24 U, Qd) (View Novorapid Review and Novorapid Label ). Patient was hospitalized.